Search alternatives:
- Subject ("Talimogene laherparepvec") »
Loading…
Interim results of a phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma
Omelchenko, Nadezhda, Younesi, Elan, Valencia, Chrysler, Ahari, Amir, Moradkhani, Ania, Chua, Victoria, Brigham, Don, Chawla, Sant P., Gordon, Erlinda Maria
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
An update on SOC-1882: A phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin for advanced leiomyosarcoma
Chawla, Neal Shiv, Omelchenko, Nadezhda, Jeffrey, Samantha, Agarwal, Anmol Dia, Chua, Victoria, Moradkhani, Ania, Quon, Doris V., Gordon, Erlinda Maria
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma
Chawla, Neal Shiv, Kim, Ted, Sherman, Travis, Dang, Jonathan, Chua, Victoria S., Moradkhani, Ania, Bhuiyan, Ishrat, Krkyan, Nathalie, Fernando, Mitchel, Colletti, Emma, Feske, William, Zheng, Kitty, Chow, Warren Allen, Agulnik, Mark, Quon, Doris, Chawla, Sant P., Gordon, Erlinda Maria, Singh, Arun S.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Loading…
A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
D'Angelo, Sandra P., Steckler, Alexa M., Lian, Ming, Wasilewski, Gloria, Lacouture, Mario E., Chapman, Paul B., Shoushtari, Alexander Noor, Ariyan, Charlotte Eielson
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
A single arm phase 2 study of talimogene laherparepvec in patients with low-risk invasive cutaneous squamous cell cancer. interim analysis
Curiel, Clara N, Stratton, Delaney, Cui, Haiyan, Roe, Denise, Arif Tiwari, Hina, Sundararajan, Srinath
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
Talimogene laherparepvec in the treatment of melanoma
Appleton, Elizabeth S, Turnbull, Samantha, Ralph, Christy, West, Emma, Scott, Karen, Harrington, Kevin, Pandha, Hardev, Melcher, Alan
Published in Expert opinion on biological therapy (03.10.2015)
Published in Expert opinion on biological therapy (03.10.2015)
Get more information
Journal Article
Loading…
Abstract P3-09-19: Preliminary safety data of intrahepatic talimogene laherparepvec and intravenous atezolizumab in patients with triple negative breast cancer
Hecht, Joel Randolph, Chan, Arlene, Baurain, Jean-Francois, Martin, Miguel, Longo-Munoz, Federico, Kalinsky, Kevin, Raman, Steven, Liu, Chunxu, Cha, Edward, Chan, Emily
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Loading…
Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or colorectal cancer (CRC)
Hecht, J. Randolph, Chan, Arlene, Martin, Miguel, Mach, Nicolas, Hurvitz, Sara A., Rottey, Sylvie, Pelzer, Uwe, Liu, Chunxu, Chan, Emily
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
Loading…
409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO)
Stewart, John, Strickler, John, Mettu, Niharika, MacLaughlan, Shannon, Niedzwiecki, Donna, Levine, Edward, Blazer, Daniel
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Loading…
OPTiM: A randomized phase III trial to evaluate the efficacy and safety of talimogene laherparepvec (T-VEC) compared with subcutaneously (sc) administered GM-CSF for the treatment (tx) of unresectable stage IIIb, IIIc, and IV melanoma
Kaufman, Howard, Wagner, Volker Jean, Goldsweig, Howard, Yao, Bin, Coffin, Robert
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Loading…
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial
Rohaan, Maartje W., Stahlie, Emma H. A., Franke, Viola, Zijlker, Lisanne P., Wilgenhof, Sofie, van der Noort, Vincent, van Akkooi, Alexander C. J., Haanen, John B. A. G.
Published in BMC cancer (04.08.2022)
Published in BMC cancer (04.08.2022)
Get full text
Journal Article
Loading…
Loading…
First-in-human CAN-3110 (ICP-34.5 expressing HSV-1 oncolytic virus) in patients with recurrent high-grade glioma
Chiocca, E. Antonio, Solomon, Isaac, Nakashima, Hiroshi, Lawler, Sean Edward, Triggs, Daniel, Zhang, Abigail, Grant, James, Reardon, David A., Wen, Patrick Y., Lee, Eudocia Quant, Ligon, Keith L., Pisano, William, Rodig, Scott J., Suva, Mario, Wucherpfennig, Kai, Gritsch, Simon, Mathewson, Nathan D., Krisky, David, Aguilar-Cordova, Estuardo, Aguilar, Laura K.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Loading…
Abstract CT004: A single arm phase 2 study of TVEC in patients with invasive cutaneous SCC: A novel therapeutic approach for low risk tumors
Curiel-Lewandrowski, Clara, Stratton, Delaney B., Adams, Anngela C., Cui, Haiyan, Roe, Denise, Sundararajan, Srinath
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
Loading…